FDA emergency authorizes Roche's monkeypox test

A real-time PCR test for the detection of monkeypox has received emergency use authorization from the US health authority.

Photo: Roche / PR

Roche has been granted emergency use authorization by the US Food and Drug Administration, FDA, for the company’s real-time PCR test for the detection of MPX, monkeypox, the company informs in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs